Lipicure Gold 10 Capsule is a combination medication containing Aspirin (75 mg), Atorvastatin (10 mg), and Clopidogrel (75 mg), indicated for the management and prevention of cardiovascular diseases. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase, thereby reducing thromboxane A2 synthesis and preventing platelet aggregation. Atorvastatin, a lipid-lowering agent belonging to the statin class, inhibits HMG-CoA reductase, leading to decreased cholesterol synthesis and improved lipid profiles, which helps reduce the risk of atherosclerosis. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP-induced platelet aggregation by blocking the P2Y12 receptor on platelets. The combined action of these agents provides synergistic effects in reducing the risk of thrombotic events such as myocardial infarction, stroke, and peripheral arterial disease in patients with established cardiovascular risk factors. Lipicure Gold 10 Capsule is typically prescribed for secondary prevention in patients with a history of coronary artery disease, acute coronary syndrome, or ischemic stroke. It should be used under medical supervision with careful monitoring for potential adverse effects, including bleeding risks associated with antiplatelet therapy and hepatic function during statin use. Patient adherence and lifestyle modifications remain essential components of optimal cardiovascular risk management.